{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:05:19Z","timestamp":1787061919718,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R33AT010604"],"award-info":[{"award-number":["R33AT010604"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Buprenorphine-naloxone is a medication shown to improve outcomes for individuals seeking treatment for opioid use disorder (OUD); however, outcomes are limited by low medication adherence rates. This is especially true during the early stages of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The present study proposes to utilize a sequential multiple assignment randomized trial design to compare two psychological interventions targeting buprenorphine-naloxone adherence: (1) contingency management (CM) and (2) brief motivational interviewing plus substance-free activities session plus mindfulness (BSM). Participants will be\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009280 adults who present to a university-based addictions clinic seeking treatment for OUD. Participants will be randomized to condition to receive 4 sessions of their assigned intervention (CM or BSM). Participants who are adherent, defined as attending physician appointments and having buprenorphine present in urine toxicology, will enter maintenance intervention for an additional 6\u00a0months. Those who are not adherent will be re-randomized to receive either the other intervention or both interventions. Follow-up will occur at 8\u00a0months post-randomization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This novel design will examine the benefit of sequential treatment decisions following non-adherence. The primary outcome of this study is buprenorphine-naloxone medication adherence, as assessed by physician visit attendance and presence of buprenorphine in urine. Results will elicit the relative efficacy of CM and BSM compared to one another and whether keeping the initial treatment approach when adding the alternative approach for initially non-adherent individuals is beneficial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04080180?term=derefinko&amp;draw=2&amp;rank=4\">NCT04080180<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07102-9","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T13:03:20Z","timestamp":1680095000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder"],"prefix":"10.1186","volume":"24","author":[{"given":"Samuel C.","family":"Peter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Witkiewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridtjof","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Chandler","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Derefinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"8","key":"7102_CR1","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","volume":"100","author":"W Ling","year":"2005","unstructured":"Ling W, Amass L, Shoptaw S, et al. A multi-center randomized trial of buprenorphine\u2013naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction. 2005;100(8):1090\u2013100.","journal-title":"Addiction"},{"issue":"2","key":"7102_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/10550490701860971","volume":"17","author":"DA Fiellin","year":"2008","unstructured":"Fiellin DA, Moore BA, Sullivan LE, et al. Long-term treatment with buprenorphine\/naloxone in primary care: Results at 2\u20135 years. Am J Addict. 2008;17(2):116\u201320.","journal-title":"Am J Addict"},{"key":"7102_CR3","unstructured":"Canadian Agency for Drugs and Technologies in Health. Buprenorphine\/naloxone versus methadone for the treatment of opioid dependence: a review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines. 2016; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385172\/. Accessed 30 Jan\u00a02019."},{"issue":"8","key":"7102_CR4","first-page":"871","volume":"15","author":"F Curcio","year":"2011","unstructured":"Curcio F, Franco T, Topa M, Baldassarre C. Buprenorphine\/naloxone versus methadone in opioid dependence: a longitudinal survey. Eur Rev Med Pharmacol Sci. 2011;15(8):871\u20134.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"7102_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMoa055255","volume":"355","author":"DA Fiellin","year":"2006","unstructured":"Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine\u2013naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355(4):365\u201374.","journal-title":"N Engl J Med"},{"issue":"1","key":"7102_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"YI Hser","year":"2014","unstructured":"Hser YI, Saxon AJ, Huang D, et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79\u201387. https:\/\/doi.org\/10.1111\/add.12333.","journal-title":"Addiction"},{"key":"7102_CR7","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine. Medication and Counseling Treatment 2016; https:\/\/www.samhsa.gov\/medication-assisted-treatment\/treatment\/buprenorphine. Accessed 14 Jan 2019."},{"key":"7102_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.addbeh.2019.05.008","volume":"96","author":"KJ Derefinko","year":"2019","unstructured":"Derefinko KJ, Salgado Garcia F, Talley K, et al. Adverse Childhood Experiences (ACES) predict opioid relapse during treatment among rural adults. Addict Behav. 2019;96:171\u20134. https:\/\/doi.org\/10.1016\/j.addbeh.2019.05.008.","journal-title":"Addict Behav"},{"issue":"2","key":"7102_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/ajad.12325","volume":"25","author":"S Kumari","year":"2016","unstructured":"Kumari S, Manalai P, Leong S, Wooditch A, Malik M, Lawson WB. Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review. Am J Addict. 2016;25(2):110\u20137. https:\/\/doi.org\/10.1111\/ajad.12325.","journal-title":"Am J Addict"},{"issue":"4","key":"7102_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jsat.2013.10.014","volume":"46","author":"J Tkacz","year":"2014","unstructured":"Tkacz J, Volpicelli J, Un H, Ruetsch C. Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients. J Subst Abuse Treat. 2014;46(4):456\u201362. https:\/\/doi.org\/10.1016\/j.jsat.2013.10.014.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"7102_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","volume":"20","author":"MD Stein","year":"2005","unstructured":"Stein MD, Cioe P, Friedmann PD. Brief report: Buprenorphine retention in primary care. J Gen Intern Med. 2005;20(11):1038\u201341. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.0228.x.","journal-title":"J Gen Intern Med"},{"key":"7102_CR12","unstructured":"The American Society of Addiction Medicine. The National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015; https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-supplement.pdf. Accessed 14 Jan 2019."},{"issue":"2","key":"7102_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","volume":"165","author":"L Dutra","year":"2008","unstructured":"Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179\u201387.","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"7102_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0376-8716(99)00068-X","volume":"58","author":"JD Griffith","year":"2000","unstructured":"Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58(1\u20132):55\u201366.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7102_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0253-7176.130960","volume":"36","author":"S Jhanjee","year":"2014","unstructured":"Jhanjee S. Evidence based psychosocial interventions in substance use. Indian J Psychol Med. 2014;36(2):112\u20138. https:\/\/doi.org\/10.4103\/0253-7176.130960.","journal-title":"Indian J Psychol Med"},{"issue":"2","key":"7102_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","volume":"101","author":"JP Lussier","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192\u2013203. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01311.x.","journal-title":"Addiction"},{"issue":"11","key":"7102_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","volume":"101","author":"M Prendergast","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101(11):1546\u201360. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01581.x.","journal-title":"Addiction"},{"key":"7102_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1969.Accessed8\/20\/2021","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis. JAMA Psychiat. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1969.Accessed8\/20\/2021.","journal-title":"JAMA Psychiat"},{"key":"7102_CR19","volume-title":"Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors","author":"GA Marlatt","year":"2005","unstructured":"Marlatt GA, Donovan DM. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. 2nd ed. New York: Guilford Press; 2005.","edition":"2"},{"key":"7102_CR20","doi-asserted-by":"crossref","unstructured":"Morin J-FG, Harris M, Conrod PJ. A review of CBT treatments for substance use disorders. 2017.","DOI":"10.1093\/oxfordhb\/9780199935291.013.57"},{"issue":"3","key":"7102_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.psc.2010.04.012","volume":"33","author":"RK McHugh","year":"2010","unstructured":"McHugh RK, Hearon BA, Otto MW. Cognitive-behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010;33(3):511\u201325. https:\/\/doi.org\/10.1016\/j.psc.2010.04.012.","journal-title":"Psychiatr Clin North Am"},{"key":"7102_CR22","doi-asserted-by":"publisher","unstructured":"Wyse JJ, Morasco BJ, Dougherty J, et al. Adjunct interventions to standard medical management of buprenorphine in outpatient settings: a systematic review of the evidence. Drug Alcohol Dependence. 2021:108923.\u00a0https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108923.","DOI":"10.1016\/j.drugalcdep.2021.108923"},{"key":"7102_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsat.2019.06.016","volume":"104","author":"TL Fazzino","year":"2019","unstructured":"Fazzino TL, Bjorlie K, Lejuez CW. A systematic review of reinforcement-based interventions for substance use: efficacy, mechanisms of action, and moderators of treatment effects. J Subst Abuse Treat. 2019;104:83\u201396. https:\/\/doi.org\/10.1016\/j.jsat.2019.06.016.","journal-title":"J Subst Abuse Treat"},{"key":"7102_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev-clinpsy-032813-153724","volume":"10","author":"WK Bickel","year":"2014","unstructured":"Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol. 2014;10:641\u201377.","journal-title":"Annu Rev Clin Psychol"},{"key":"7102_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.paid.2017.02.023","volume":"111","author":"CA Lee","year":"2017","unstructured":"Lee CA, Derefinko KJ, Milich R, Lynam DR, DeWall CN. Longitudinal and reciprocal relations between delay discounting and crime. Pers Individ Dif. 2017;111:193\u20138. https:\/\/doi.org\/10.1016\/j.paid.2017.02.023.","journal-title":"Pers Individ Dif"},{"issue":"6","key":"7102_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0306-4603(02)00220-4","volume":"28","author":"SH Kollins","year":"2003","unstructured":"Kollins SH. Delay discounting is associated with substance use in college students. Addict Behav. 2003;28(6):1167\u201373.","journal-title":"Addict Behav"},{"issue":"3","key":"7102_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0021-843X.110.3.482","volume":"110","author":"NM Petry","year":"2001","unstructured":"Petry NM. Pathological gamblers, with and without substance abuse disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001;110(3):482.","journal-title":"J Abnorm Psychol"},{"issue":"1","key":"7102_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0376-8716(99)00010-1","volume":"56","author":"NM Petry","year":"1999","unstructured":"Petry NM, Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend. 1999;56(1):25\u201332.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"7102_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1037\/1064-1297.11.1.18","volume":"11","author":"SF Coffey","year":"2003","unstructured":"Coffey SF, Gudleski GD, Saladin ME, Brady KT. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol. 2003;11(1):18.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"7","key":"7102_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1037\/ccp0000412","volume":"87","author":"JG Murphy","year":"2019","unstructured":"Murphy JG, Dennhardt AA, Martens MP, Borsari B, Witkiewitz K, Meshesha LZ. A randomized clinical trial evaluating the efficacy of a brief alcohol intervention supplemented with a substance-free activity session or relaxation training. J Consult Clin Psychol. 2019;87(7):657\u201369. https:\/\/doi.org\/10.1037\/ccp0000412.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"7102_CR31","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1037\/a0028763","volume":"80","author":"JG Murphy","year":"2012","unstructured":"Murphy JG, Dennhardt AA, Skidmore JR, et al. A randomized controlled trial of a behavioral economic supplement to brief motivational interventions for college drinking. J Consult Clin Psychol. 2012;80(5):876\u201386. https:\/\/doi.org\/10.1037\/a0028763.","journal-title":"J Consult Clin Psychol"},{"issue":"11","key":"7102_CR32","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1016\/j.addbeh.2007.05.015","volume":"32","author":"JG Murphy","year":"2007","unstructured":"Murphy JG, Correia CJ, Barnett NP. Behavioral economic approaches to reduce college student drinking. Addict Behav. 2007;32(11):2573\u201385. https:\/\/doi.org\/10.1016\/j.addbeh.2007.05.015.","journal-title":"Addict Behav"},{"issue":"3","key":"7102_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1891\/jcop.2005.19.3.211","volume":"19","author":"K Witkiewitz","year":"2005","unstructured":"Witkiewitz K, Marlatt GA, Walker D. Mindfulness-based relapse prevention for alcohol and substance use disorders. J Cogn Psychother. 2005;19(3):211\u201328.","journal-title":"J Cogn Psychother"},{"issue":"5","key":"7102_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3109\/10826084.2014.891845","volume":"49","author":"K Witkiewitz","year":"2014","unstructured":"Witkiewitz K, Bowen S, Harrop EN, Douglas H, Enkema M, Sedgwick C. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst Use Misuse. 2014;49(5):513\u201324. https:\/\/doi.org\/10.3109\/10826084.2014.891845.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"7102_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1521-0391.2014.12092.x","volume":"23","author":"NM Petry","year":"2014","unstructured":"Petry NM, DePhilippis D, Rash CJ, Drapkin M, McKay JR. Nationwide dissemination of contingency management: the veterans administration initiative. Am J Addict. 2014;23(3):205\u201310. https:\/\/doi.org\/10.1111\/j.1521-0391.2014.12092.x.","journal-title":"Am J Addict"},{"issue":"1","key":"7102_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2006.03.010","volume":"85","author":"KC Kirby","year":"2006","unstructured":"Kirby KC, Benishek LA, Dugosh KL, Kerwin ME. Substance abuse treatment providers\u2019 beliefs and objections regarding contingency management: implications for dissemination. Drug Alcohol Depend. 2006;85(1):19\u201327. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.03.010.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7102_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1037\/0022-006X.71.2.320","volume":"71","author":"N Messina","year":"2003","unstructured":"Messina N, Farabee D, Rawson R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. J Consult Clin Psychol. 2003;71(2):320.","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"7102_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0376-8716(02)00023-6","volume":"67","author":"KL Preston","year":"2002","unstructured":"Preston KL, Umbricht A, Epstein DH. Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend. 2002;67(2):125\u201337.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"7102_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/archpsyc.59.9.817","volume":"59","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Huber A, McCann M, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59(9):817\u201324. https:\/\/doi.org\/10.1001\/archpsyc.59.9.817.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"7102_CR40","first-page":"e172","volume":"23","author":"C Ruetsch","year":"2017","unstructured":"Ruetsch C, Tkacz J, Nadipelli VR, et al. Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes. Am J Manag Care. 2017;23(6):e172\u20139.","journal-title":"Am J Manag Care"},{"issue":"1","key":"7102_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1151\/spp032155","volume":"2","author":"NM Petry","year":"2003","unstructured":"Petry NM, Bohn MJ. Fishbowls and candy bars: using low-cost incentives to increase treatment retention. Science & Practice Perspectives. 2003;2(1):55.","journal-title":"Science & Practice Perspectives"},{"key":"7102_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cobeha.2017.06.002","volume":"17","author":"DL Schacter","year":"2017","unstructured":"Schacter DL, Benoit RG, Szpunar KK. Episodic future thinking: mechanisms and functions. Curr Opin Behav Sci. 2017;17:41\u201350. https:\/\/doi.org\/10.1016\/j.cobeha.2017.06.002.","journal-title":"Curr Opin Behav Sci"},{"issue":"12","key":"7102_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1364-6613(00)01804-0","volume":"5","author":"CM Atance","year":"2001","unstructured":"Atance CM, O\u2019Neill DK. Episodic future thinking. Trends Cogn Sci. 2001;5(12):533\u20139.","journal-title":"Trends Cogn Sci"},{"key":"7102_CR44","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"1","key":"7102_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1037\/0096-3445.128.1.78","volume":"128","author":"KN Kirby","year":"1999","unstructured":"Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128(1):78\u201387.","journal-title":"J Exp Psychol Gen"},{"key":"7102_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.paid.2017.02.023","volume":"111","author":"CA Lee","year":"2017","unstructured":"Lee CA, Derefinko KJ, Milich R, Lynam DR, DeWall CN. Longitudinal and reciprocal relations between delay discounting and crime. Personality Individ Differ. 2017;111:193\u20138.","journal-title":"Personality Individ Differ"},{"issue":"1","key":"7102_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1037\/pha0000052","volume":"24","author":"AM Pickover","year":"2016","unstructured":"Pickover AM, Messina BG, Correia CJ, Garza KB, Murphy JG. A behavioral economic analysis of the nonmedical use of prescription drugs among young adults. Exp Clin Psychopharmacol. 2016;24(1):38\u201347. https:\/\/doi.org\/10.1037\/pha0000052.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"7102_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.15288\/jsad.2016.77.656","volume":"77","author":"M Amlung","year":"2016","unstructured":"Amlung M, Morris DH, Hatz LE, Teeters JB, Murphy JG, McCarthy DM. Drinking-and-driving-related cognitions mediate the relationship between alcohol demand and alcohol-impaired driving. J Stud Alcohol Drugs. 2016;77(4):656\u201360.","journal-title":"J Stud Alcohol Drugs"},{"issue":"4","key":"7102_CR49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0005-7894(98)80050-6","volume":"29","author":"WK Bickel","year":"1998","unstructured":"Bickel WK, Madden GJ, Petry NM. The price of change: The behavioral economics of drug dependence. Behav Ther. 1998;29(4):545\u201365. https:\/\/doi.org\/10.1016\/S0005-7894(98)80050-6.","journal-title":"Behav Ther"},{"key":"7102_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1037\/1064-1297.14.2.219","volume":"14","author":"JG Murphy","year":"2006","unstructured":"Murphy JG, MacKillop J. Relative reinforcing efficacy of alcohol among college student drinkers. Exp Clin Psychopharmacol. 2006;14:219\u201327.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"7102_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1037\/a0017684","volume":"17","author":"JG Murphy","year":"2009","unstructured":"Murphy JG, MacKillop J, Skidmore JR, Pederson AA. Reliability and validity of a demand curve measure of alcohol reinforcement. Exp Clin Psychopharmacol. 2009;17(6):396\u2013404. https:\/\/doi.org\/10.1037\/a0017684.","journal-title":"Exp Clin Psychopharmacol"},{"key":"7102_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.beproc.2015.02.012","volume":"113","author":"M Amlung","year":"2015","unstructured":"Amlung M, MacKillop J. Further evidence of close correspondence for alcohol demand decision making for hypothetical and incentivized rewards. Behav Processes. 2015;113:187\u201391. https:\/\/doi.org\/10.1016\/j.beproc.2015.02.012.","journal-title":"Behav Processes"},{"issue":"1","key":"7102_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jeab.121","volume":"103","author":"AA Dennhardt","year":"2015","unstructured":"Dennhardt AA, Yurasek AM, Murphy JG. Change in delay discounting and substance reward value following a brief alcohol and drug use intervention. J Exp Anal Behav. 2015;103(1):125\u201340. https:\/\/doi.org\/10.1002\/jeab.121.","journal-title":"J Exp Anal Behav"},{"issue":"2\u20133","key":"7102_CR54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.drugalcdep.2007.01.002","volume":"89","author":"J MacKillop","year":"2007","unstructured":"MacKillop J, Murphy JG. A behavioral economic measure of demand for alcohol predicts brief intervention outcomes. Drug Alcohol Depend. 2007;89(2\u20133):227\u201333. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.01.002.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"7102_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1037\/a0035318","volume":"22","author":"RL Collins","year":"2014","unstructured":"Collins RL, Vincent PC, Yu J, Liu L, Epstein LH. A behavioral economic approach to assessing demand for marijuana. Exp Clin Psychopharmacol. 2014;22(3):211\u201321. https:\/\/doi.org\/10.1037\/a0035318.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"7102_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1037\/1064-1297.16.1.57","volume":"16","author":"J MacKillop","year":"2008","unstructured":"MacKillop J, Murphy JG, Ray LA, et al. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol. 2008;16(1):57\u201365. https:\/\/doi.org\/10.1037\/1064-1297.16.1.57.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"12","key":"7102_CR57","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1111\/acer.13255","volume":"40","author":"KJ Joyner","year":"2016","unstructured":"Joyner KJ, Pickover AM, Soltis KE, Dennhardt AA, Martens MP, Murphy JG. Deficits in access to reward are associated with college student alcohol use disorder. Alcohol Clin Exp Res. 2016;40(12):2685\u201391. https:\/\/doi.org\/10.1111\/acer.13255.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"7102_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejpain.2005.06.002","volume":"10","author":"T Mendoza","year":"2006","unstructured":"Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006;10(4):353\u201361. https:\/\/doi.org\/10.1016\/j.ejpain.2005.06.002.","journal-title":"Eur J Pain"},{"key":"7102_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1477-7525-8-47","volume":"8","author":"HH K\u00f6nig","year":"2010","unstructured":"K\u00f6nig HH, Born A, G\u00fcnther O, et al. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health Qual Life Outcomes. 2010;8:47. https:\/\/doi.org\/10.1186\/1477-7525-8-47.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"7102_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JB, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317\u201325. https:\/\/doi.org\/10.7326\/0003-4819-146-5-200703060-00004.","journal-title":"Ann Intern Med"},{"issue":"6","key":"7102_CR61","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","volume":"24","author":"EE Krebs","year":"2009","unstructured":"Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733\u20138. https:\/\/doi.org\/10.1007\/s11606-009-0981-1.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"7102_CR62","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/MLR.0000000000000497","volume":"54","author":"J Kean","year":"2016","unstructured":"Kean J, Monahan P, Kroenke K, et al. Comparative responsiveness of the PROMIS pain interference short forms, brief pain inventory, PEG, and SF-36 bodily pain subscale. Med Care. 2016;54(4):414.","journal-title":"Med Care"},{"issue":"11","key":"7102_CR63","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.Mlr.0000093487.78664.3c","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284\u201392. https:\/\/doi.org\/10.1097\/01.Mlr.0000093487.78664.3c.","journal-title":"Med Care"},{"issue":"10","key":"7102_CR64","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/m16-0317","volume":"165","author":"J McNeely","year":"2016","unstructured":"McNeely J, Wu LT, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690\u20139. https:\/\/doi.org\/10.7326\/m16-0317.","journal-title":"Ann Intern Med"},{"key":"7102_CR65","unstructured":"American College of Academic Addiction Medicine. Accredited Fellowships. 2020; https:\/\/www.acaam.org\/accreditedfellowships\/. Accessed 17 Feb 2020."},{"issue":"1","key":"7102_CR66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1037\/a0030992","volume":"28","author":"SM Robinson","year":"2014","unstructured":"Robinson SM, Sobell LC, Sobell MB, Leo GI. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2014;28(1):154\u201362. https:\/\/doi.org\/10.1037\/a0030992.","journal-title":"Psychol Addict Behav"},{"key":"7102_CR67","doi-asserted-by":"publisher","unstructured":"McHugh RK, Fitzmaurice GM, Carroll KM, et al. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Dependence. 2014;0:121\u20136.\u00a0https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.002.","DOI":"10.1016\/j.drugalcdep.2014.10.002"},{"issue":"7","key":"7102_CR68","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1176\/appi.ajp.160.7.1320","volume":"160","author":"RD Weiss","year":"2003","unstructured":"Weiss RD, Griffin ML, Mazurick C, et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003;160(7):1320\u20135. https:\/\/doi.org\/10.1176\/appi.ajp.160.7.1320.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"7102_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00898416","volume":"11","author":"ME Procidano","year":"1983","unstructured":"Procidano ME, Heller K. Measures of perceived social support from friends and from family: Three validation studies. Am J Community Psychol. 1983;11(1):1\u201324.","journal-title":"Am J Community Psychol"},{"issue":"3","key":"7102_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"issue":"6","key":"7102_CR71","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0895-4356(03)00053-2","volume":"56","author":"G Ogedegbe","year":"2003","unstructured":"Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56(6):520\u20139.","journal-title":"J Clin Epidemiol"},{"key":"7102_CR72","doi-asserted-by":"publisher","unstructured":"Ross TP, Ross LT, Short SD, Cataldo S. The Multidimensional Health Locus of Control Scale: psychometric properties and form equivalence. Psychol Rep. 2015;116(3):889\u2013913. https:\/\/doi.org\/10.2466\/09.02.PR0.116k29w3. Accessed 03 Nov\u00a02021.","DOI":"10.2466\/09.02.PR0.116k29w3"},{"key":"7102_CR73","unstructured":"Sobell L, Sobell M, Buchan G. Timeline followback method (drugs, cigarettes, and marijuana); 1996."},{"issue":"2","key":"7102_CR74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"key":"7102_CR75","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Psychology Press; 1988.","edition":"2"},{"key":"7102_CR76","unstructured":"Almirall D, Compton SN, Gunlicks-Stoessel M, Duan N, Murphy SA. Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy (No. 11\u2013115). University Park, PA: The Methodology Center, The Pennsylvania State University;2011."},{"key":"7102_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7428-9","volume-title":"Statistical methods for dynamic treatment regimes: reinforcement learning, causal inference, and personalized medicine","author":"B Chakraborty","year":"2013","unstructured":"Chakraborty B, Moodie EEM. Statistical methods for dynamic treatment regimes: reinforcement learning, causal inference, and personalized medicine. New York: Springer; 2013."},{"key":"7102_CR78","doi-asserted-by":"crossref","unstructured":"Kosorok MR, Moodie EEM, eds. Adaptive treatment strategies in practice: planning trials and analyzing data for personalized medicine. Philadelphia: SIAM-Society for Industrial and Applied Mathematics; 2016. ASA-SIAM Series on Statistics and Applied Mathematics.","DOI":"10.1137\/1.9781611974188"},{"key":"7102_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/0471740136","volume-title":"Clinical trials - a methodologic perspective","author":"S Piantadosi","year":"2005","unstructured":"Piantadosi S. Clinical trials - a methodologic perspective. 2nd ed. Hoboken, New Jersey: Wiley; 2005.","edition":"2"},{"issue":"2","key":"7102_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-1781(80)90069-4","volume":"2","author":"RE Roberts","year":"1980","unstructured":"Roberts RE. Reliability of the CES-D Scale in different ethnic contexts. Psychiatry Res. 1980;2(2):125\u201334. https:\/\/doi.org\/10.1016\/0165-1781(80)90069-4.","journal-title":"Psychiatry Res"},{"key":"7102_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken, NJ: Wiley; 2002.","edition":"2"},{"key":"7102_CR82","doi-asserted-by":"publisher","DOI":"10.1201\/9780429492259","volume-title":"Flexible imputation of missing data","author":"S van Buuren","year":"2018","unstructured":"van Buuren S. Flexible imputation of missing data. 2nd ed. Boca Raton, FL: CRC Press; 2018.","edition":"2"},{"key":"7102_CR83","unstructured":"Varadhan R, Stuart EA, Louis TA, Segal JB, Weiss CO. Review of guidance documents for selected methods in patient centered outcomes research: standards in addressing heterogeneity of treatment effectiveness in observational and experimental patient centered outcomes research. http:\/\/www.pcori.org\/assets\/Standards-in-Addressing-Heterogeneity-of-Treatment-Effectiveness-in-Observational-and-Experimental-Patient-Centered-Outcomes-Research.pdf: PCORI; 2012. Accessed 23 Jan\u00a02015."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07102-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07102-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07102-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T13:04:33Z","timestamp":1680095073000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07102-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7102"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07102-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at the University of Tennessee Health Science Center (FWA00002301). Informed consent will be obtained from all participants before research procedures commence.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}